Skip to main content

Advertisement

Table 1 Baseline characteristics of patients in 2006 and 2011 according to their enrolment into DMPs and according to guideline care

From: The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study

  2006 (baseline) 2011 (follow-up)
n = 312 DMP (CHD or DM) Guideline carea n = 210 DMP (CHD or DM) Guideline carea
Yes (n = 237) No (n = 75)   Yes (n = 186) No (n = 114)   Yes (n = 161) No (n = 49)   Yes (n = 120) No (n = 76)  
Mean Std Mean Mean p-value Mean Mean p-value Mean Std Mean Mean p-value Mean Mean p-value
Age 68.2 8.6 67.7 69.9 0.052 67.1 69.3 0.033 72.1 8.3 71.6 73.7 0.116 70.4 74.3 0.001
Diabetes duration (years) 8.5 7.5 8.5 8.7 0.838 8.7 8.2 0.661 9.9 7.0 10.7 7.2 0.006 10.2 8.5 0.144
Time since first MI 9.3 5.3 8.7 11.0 0.001 9.0 9.9 0.123 14.1 5.2 14.1 14.1 0.956 13.6 15.0 0.069
Number of reinfarctions 0.2 0.5 0.2 0.2 0.233 0.2 0.1 0.073 0.1 0.4 0.1 0.1 0.163 0.1 0.1 0.347
Quality of life (EQ-5D) 0.81 0.23 0.82 0.80 0.474 0.84 0.77 0.007 0.81 0.23 0.81 0.78 0.466 0.83 0.78 0.099
  1. DMP disease management program, CHD coronary heart disease, DM diabetes mellitus
  2. aCounseling on two out of the three lifestyle topics (smoking, diet, exercise) and intake of a platelet aggregation inhibitor and a statin and either renin–angiotensin inhibitors or a beta blocker
  n % % % p-value % % p-value n % % % p-value % % p-value
Sex
 Women 64 20.5 49 15 0.900 37 23 0.953 44 21.0 37 7 0.190 20 18 0.226
 Men 248 79.5 188 60 149 91 166 79.1 124 42 100 58
Education
 Low (<9 years of school) 221 77.8 177 44 0.025 133 80 0.596 152 77.6 116 36 0.895 91 51 0.666
 High (≥9 years of school) 63 22.2 42 21 41 21 44 22.5 34 10 26 17
Smoking
 Never 92 29.9 66 26 0.459 55 31 0.851 70 33.8 52 18 0.846 39 25 0.552
 Ex-smoker 179 58.1 138 41 105 69 117 56.5 90 27 67 43
 Current smoker 37 12.0 30 7 23 14 20 9.7 16 4 14 5
Weight status
 Normal (20 ≤ BMI < 25) 37 12.2 26 11 0.484 20 16 0.461 30 14.9 18 12 0.092 11 16 0.041
 Overweight (25 ≤ BMI < 30) 146 48.0 115 31 91 47 91 45.1 71 20 59 28
 Obese (BMI ≥ 30) 121 39.8 90 31 72 46 81 40.1 64 17 47 30
Diabetes treatment
 No medication 59 19.7 41 18 0.418 35 21 0.995 56 27.3 41 15 0.617 33 21 0.955
 Oral medication only 140 46.7 108 32 86 51 96 46.8 74 22 56 35
 Insulin therapy 101 33.7 79 22 59 36 53 25.9 43 10 30 17
Guideline carea
 No 114 38.0 76 38 0.001 76 38.8 59 17 0.876
 Yes 186 62.0 154 32 120 61.2 92 28
  1. DMP disease management program, CHD coronary heart disease, DM diabetes mellitus
  2. aCounseling on two out of the three lifestyle topics (smoking, diet, exercise) and intake of a platelet aggregation inhibitor and a statin and either renin–angiotensin inhibitors or a beta blocker